331 related articles for article (PubMed ID: 17189394)
1. Update on epidermal growth factor receptor mutations in non-small cell lung cancer.
Riely GJ; Politi KA; Miller VA; Pao W
Clin Cancer Res; 2006 Dec; 12(24):7232-41. PubMed ID: 17189394
[TBL] [Abstract][Full Text] [Related]
2. Activating and resistance mutations of the epidermal growth factor receptor (EGFR) gene and non-small cell lung cancer: a clinical reality.
Taus A; Vollmer I; Arriola E
Arch Bronconeumol; 2011 Feb; 47(2):103-5. PubMed ID: 20678850
[TBL] [Abstract][Full Text] [Related]
3. Impact of EGFR mutation analysis in non-small cell lung cancer.
Yamamoto H; Toyooka S; Mitsudomi T
Lung Cancer; 2009 Mar; 63(3):315-21. PubMed ID: 18760859
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor mutations in lung cancer.
Sharma SV; Bell DW; Settleman J; Haber DA
Nat Rev Cancer; 2007 Mar; 7(3):169-81. PubMed ID: 17318210
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor (EGFR) double-activating somatic mutations in exons 19 and 21 in Japanese non-small cell lung cancer patients.
Masago K; Fujita S; Kim YH; Ichikawa M; Hatachi Y; Fukuhara A; Nagai H; Irisa K; Mio T; Mishima M
Cancer Genet Cytogenet; 2009 Dec; 195(2):179-82. PubMed ID: 19963121
[No Abstract] [Full Text] [Related]
6. Functional analysis of epidermal growth factor receptor (EGFR) mutations and potential implications for EGFR targeted therapy.
Kancha RK; von Bubnoff N; Peschel C; Duyster J
Clin Cancer Res; 2009 Jan; 15(2):460-7. PubMed ID: 19147750
[TBL] [Abstract][Full Text] [Related]
7. EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients.
Bae NC; Chae MH; Lee MH; Kim KM; Lee EB; Kim CH; Park TI; Han SB; Jheon S; Jung TH; Park JY
Cancer Genet Cytogenet; 2007 Mar; 173(2):107-13. PubMed ID: 17321325
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor mutations in lung cancers.
Yatabe Y; Mitsudomi T
Pathol Int; 2007 May; 57(5):233-44. PubMed ID: 17493170
[TBL] [Abstract][Full Text] [Related]
9. HKI-272 in non small cell lung cancer.
Wong KK
Clin Cancer Res; 2007 Aug; 13(15 Pt 2):s4593-6. PubMed ID: 17671147
[TBL] [Abstract][Full Text] [Related]
10. First-line gefitinib for patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations without indication for chemotherapy.
Inoue A; Kobayashi K; Usui K; Maemondo M; Okinaga S; Mikami I; Ando M; Yamazaki K; Saijo Y; Gemma A; Miyazawa H; Tanaka T; Ikebuchi K; Nukiwa T; Morita S; Hagiwara K;
J Clin Oncol; 2009 Mar; 27(9):1394-400. PubMed ID: 19224850
[TBL] [Abstract][Full Text] [Related]
11. Overview of molecular testing in non-small-cell lung cancer: mutational analysis, gene copy number, protein expression and other biomarkers of EGFR for the prediction of response to tyrosine kinase inhibitors.
John T; Liu G; Tsao MS
Oncogene; 2009 Aug; 28 Suppl 1():S14-23. PubMed ID: 19680292
[TBL] [Abstract][Full Text] [Related]
12. Single-molecule detection of epidermal growth factor receptor mutations in plasma by microfluidics digital PCR in non-small cell lung cancer patients.
Yung TK; Chan KC; Mok TS; Tong J; To KF; Lo YM
Clin Cancer Res; 2009 Mar; 15(6):2076-84. PubMed ID: 19276259
[TBL] [Abstract][Full Text] [Related]
13. Rapid detection of epidermal growth factor receptor mutations in lung cancer by the SMart-Amplification Process.
Hoshi K; Takakura H; Mitani Y; Tatsumi K; Momiyama N; Ichikawa Y; Togo S; Miyagi T; Kawai Y; Kogo Y; Kikuchi T; Kato C; Arakawa T; Uno S; Cizdziel PE; Lezhava A; Ogawa N; Hayashizaki Y; Shimada H
Clin Cancer Res; 2007 Sep; 13(17):4974-83. PubMed ID: 17785547
[TBL] [Abstract][Full Text] [Related]
14. Sequential occurrence of non-small cell and small cell lung cancer with the same EGFR mutation.
Morinaga R; Okamoto I; Furuta K; Kawano Y; Sekijima M; Dote K; Satou T; Nishio K; Fukuoka M; Nakagawa K
Lung Cancer; 2007 Dec; 58(3):411-3. PubMed ID: 17601631
[TBL] [Abstract][Full Text] [Related]
15. Searching for a magic bullet in NSCLC: the role of epidermal growth factor receptor mutations and tyrosine kinase inhibitors.
Wong KK
Lung Cancer; 2008 Jun; 60 Suppl 2():S10-8. PubMed ID: 18513579
[TBL] [Abstract][Full Text] [Related]
16. Detection and comparison of epidermal growth factor receptor mutations in cells and fluid of malignant pleural effusion in non-small cell lung cancer.
Zhang X; Zhao Y; Wang M; Yap WS; Chang AY
Lung Cancer; 2008 May; 60(2):175-82. PubMed ID: 18061305
[TBL] [Abstract][Full Text] [Related]
17. [Advances in research of molecular imaging of epidermal growth factor receptor in non-small cell lung cancer].
Yu JM; Liu NB
Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):81-4. PubMed ID: 19538879
[No Abstract] [Full Text] [Related]
18. Mouse models of human non-small-cell lung cancer: raising the bar.
Kim CF; Jackson EL; Kirsch DG; Grimm J; Shaw AT; Lane K; Kissil J; Olive KP; Sweet-Cordero A; Weissleder R; Jacks T
Cold Spring Harb Symp Quant Biol; 2005; 70():241-50. PubMed ID: 16869760
[TBL] [Abstract][Full Text] [Related]
19. A semiparametric empirical likelihood method for biased sampling schemes with auxiliary covariates.
Wang X; Zhou H
Biometrics; 2006 Dec; 62(4):1149-60. PubMed ID: 17156290
[TBL] [Abstract][Full Text] [Related]
20. Molecular marker analyses from the SATURN trial.
Brugger W
Clin Adv Hematol Oncol; 2012 Jan; 10(1):33-4. PubMed ID: 22398805
[No Abstract] [Full Text] [Related]
[Next] [New Search]
